Iwasaki H
First Department of Surgery, Yokohama City University School of Medicine, Japan.
Int Surg. 1996 Jan-Mar;81(1):71-6.
Many short sequence repeat polymorphisms (SSRP) have been reported recently. There have been few reports of loss of heterozygosity (LOH) in tumors, employing these SSRP markers. The author examined loss of heterozygosity in 19 MEN-1 tumors and 43 sporadic parathyroid adenomas. All 19 (100%) MEN-1 tumors showed allelic loss on chromosome 11q. 15 out of 43 (34.9%) sporadic parathyroid adenomas showed allelic loss at the same locus on chromosome 11 as MEN-1 tumors. There was no significant allelic loss region on other chromosomes. These results suggest that the MEN-1 gene, which plays the role of a tumor suppressor gene in parathyroid tissue, has been localized telomeric to PYGM and centromeric INT2 loci on chromosome 11q13 and that the MEN-1 gene can be a tumor suppressor gene for sporadic parathyroid adenomas.
最近报道了许多短串联重复多态性(SSRP)。利用这些SSRP标记对肿瘤杂合性缺失(LOH)的报道很少。作者检测了19例MEN - 1肿瘤和43例散发性甲状旁腺腺瘤中的杂合性缺失情况。所有19例(100%)MEN - 1肿瘤均显示11q染色体上等位基因缺失。43例散发性甲状旁腺腺瘤中有15例(34.9%)在11号染色体上与MEN - 1肿瘤相同的位点显示等位基因缺失。其他染色体上没有明显的等位基因缺失区域。这些结果表明,在甲状旁腺组织中起肿瘤抑制基因作用的MEN - 1基因已定位于11q13上PYGM的端粒和INT2基因座的着丝粒附近,并且MEN - 1基因可能是散发性甲状旁腺腺瘤的肿瘤抑制基因。